The Lancet Commission on diabetes: using data to transform diabetes care and patient lives

JCN Chan, LL Lim, NJ Wareham, JE Shaw, TJ Orchard… - The Lancet, 2020 - thelancet.com
Executive summary 2020 will go down in history as the year when the global community was
awakened to the fragility of human health and the interdependence of the ecosystem …

Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3)

JBS Board - Heart, 2014 - heart.bmj.com
Executive summary Despite the improvements in outcomes for cardiovascular disease
(CVD) over the last 20 years, it remains the major cause of morbidity and mortality in the …

[HTML][HTML] KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease

IH de Boer, ML Caramori, JCN Chan… - Kidney …, 2020 - kidney-international.org
This is an opportune time to publish the first KDIGO 2020 Clinical Practice Guideline for
Diabetes Management in Chronic Kidney Disease (CKD). Worldwide, the estimated number …

Diabetes management in chronic kidney disease: synopsis of the 2020 KDIGO clinical practice guideline

SD Navaneethan, S Zoungas, ML Caramori… - Annals of internal …, 2021 - acpjournals.org
Description: The Kidney Disease: Improving Global Outcomes (KDIGO) organization
developed a clinical practice guideline in 2020 for the management of patients with diabetes …

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and …

Authors/Task Force Members, L Rydén… - European heart …, 2013 - academic.oup.com
ESC Guidelines 3039 administrative staff and by the referees and supervisory committees of
the two organizations. It is our hope that this huge effort has generated guidelines that will …

Cost-effectiveness of interventions to manage diabetes: has the evidence changed since 2008?

KR Siegel, MK Ali, X Zhou, BP Ng, S Jawanda… - Diabetes …, 2020 - Am Diabetes Assoc
OBJECTIVE To synthesize updated evidence on the cost-effectiveness (CE) of interventions
to manage diabetes, its complications, and comorbidities. RESEARCH DESIGN AND …

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for …

HW Rodbard, PS Jellinger, JA Davidson, D Einhorn… - Endocrine practice, 2009 - Elsevier
This report presents an algorithm to assist primary care physicians, endocrinologists, and
others in the management of adult, nonpregnant patients with type 2 diabetes mellitus. In …

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

B Hemmingsen, SS Lund, C Gluud… - Cochrane Database …, 2013 - cochranelibrary.com
Background Patients with type 2 diabetes mellitus (T2D) have an increased risk of
cardiovascular disease and mortality compared to the background population …

Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

B Hemmingsen, SS Lund, C Gluud, A Vaag, T Almdal… - Bmj, 2011 - bmj.com
Objective To assess the effect of targeting intensive glycaemic control versus conventional
glycaemic control on all cause mortality and cardiovascular mortality, non-fatal myocardial …

Blood pressure control for diabetic retinopathy

DV Do, G Han, SA Abariga, G Sleilati… - Cochrane Database …, 2023 - cochranelibrary.com
Background Diabetic retinopathy is a common complication of diabetes and a leading cause
of visual impairment and blindness. Research has established the importance of blood …